New York Life Investment Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,250
| Closed | -$362K | – | 945 |
|
|
2024
Q1 | $362K | Sell |
21,250
-12,509
| -37% | -$213K | ﹤0.01% | 1164 |
|
|
2023
Q4 | $344K | Sell |
33,759
-1,045
| -3% | -$10.6K | ﹤0.01% | 1133 |
|
|
2023
Q3 | $315K | Sell |
34,804
-5,483
| -14% | -$49.6K | ﹤0.01% | 1110 |
|
|
2023
Q2 | $433K | Sell |
40,287
-3,618
| -8% | -$38.9K | ﹤0.01% | 877 |
|
|
2023
Q1 | $449K | Buy |
+43,905
| New | +$449K | 0.01% | 1139 |
|